Cargando…

Irreversible fatal contrast-induced encephalopathy: a case report

BACKGROUND: Contrast-induced encephalopathy (CIE) is a well-known complication of iodinated contrast agents during angiography and vascular interventions. It can manifest as hemiparesis, cortical blindness, speech changes, Parkinsonism, confusion, seizure, and coma. Most of the reported CIE cases ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wei, Zhang, Jinping, Song, Yun, Sun, Lili, Zheng, Meimei, Yin, Hao, Zhang, Jun, Wang, Wei, Han, Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437917/
https://www.ncbi.nlm.nih.gov/pubmed/30922249
http://dx.doi.org/10.1186/s12883-019-1279-5
_version_ 1783407018359390208
author Zhao, Wei
Zhang, Jinping
Song, Yun
Sun, Lili
Zheng, Meimei
Yin, Hao
Zhang, Jun
Wang, Wei
Han, Ju
author_facet Zhao, Wei
Zhang, Jinping
Song, Yun
Sun, Lili
Zheng, Meimei
Yin, Hao
Zhang, Jun
Wang, Wei
Han, Ju
author_sort Zhao, Wei
collection PubMed
description BACKGROUND: Contrast-induced encephalopathy (CIE) is a well-known complication of iodinated contrast agents during angiography and vascular interventions. It can manifest as hemiparesis, cortical blindness, speech changes, Parkinsonism, confusion, seizure, and coma. Most of the reported CIE cases have been transient and reversible. Irreversible fatal CIE cases have been rarely reported. All the fatal CIE cases reported involved the use of ionic high osmolar contrast agents. Here, we document a heretofore unreported fatal CIE after digital subtraction angiography (DSA) using iopamidol, which is a type of non-ionic monomer low osmolar contrast agent. CASE PRESENTATION: A 71-year-old woman was admitted to our Department of Neurology for tinnitus in the head. The cerebral magnetic resonance angiography (MRA) detected atherosclerotic cerebral arteries and bilateral stenosis of the middle cerebral arteries. The patient underwent DSA for further diagnostic work-up. The total amount of iopamidol used during the procedure was 110 ml. The patient experienced headache during the procedure, followed by dizziness with nausea and vomiting. Despite treatment with anti-oedema medications, her clinical status was gradually deteriorating and ended up with deep coma due to irreversible cerebral oedema which was confirmed by cerebral computed tomography (CT). Finally, the patient died 56 days after the procedure due to irreversible fatal cerebral oedema. CONCLUSIONS: This report documents that iopamidol-induced encephalopathy may not always have a benign outcome and can result in irreversible fatal cerebral oedema.
format Online
Article
Text
id pubmed-6437917
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64379172019-04-08 Irreversible fatal contrast-induced encephalopathy: a case report Zhao, Wei Zhang, Jinping Song, Yun Sun, Lili Zheng, Meimei Yin, Hao Zhang, Jun Wang, Wei Han, Ju BMC Neurol Case Report BACKGROUND: Contrast-induced encephalopathy (CIE) is a well-known complication of iodinated contrast agents during angiography and vascular interventions. It can manifest as hemiparesis, cortical blindness, speech changes, Parkinsonism, confusion, seizure, and coma. Most of the reported CIE cases have been transient and reversible. Irreversible fatal CIE cases have been rarely reported. All the fatal CIE cases reported involved the use of ionic high osmolar contrast agents. Here, we document a heretofore unreported fatal CIE after digital subtraction angiography (DSA) using iopamidol, which is a type of non-ionic monomer low osmolar contrast agent. CASE PRESENTATION: A 71-year-old woman was admitted to our Department of Neurology for tinnitus in the head. The cerebral magnetic resonance angiography (MRA) detected atherosclerotic cerebral arteries and bilateral stenosis of the middle cerebral arteries. The patient underwent DSA for further diagnostic work-up. The total amount of iopamidol used during the procedure was 110 ml. The patient experienced headache during the procedure, followed by dizziness with nausea and vomiting. Despite treatment with anti-oedema medications, her clinical status was gradually deteriorating and ended up with deep coma due to irreversible cerebral oedema which was confirmed by cerebral computed tomography (CT). Finally, the patient died 56 days after the procedure due to irreversible fatal cerebral oedema. CONCLUSIONS: This report documents that iopamidol-induced encephalopathy may not always have a benign outcome and can result in irreversible fatal cerebral oedema. BioMed Central 2019-03-28 /pmc/articles/PMC6437917/ /pubmed/30922249 http://dx.doi.org/10.1186/s12883-019-1279-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Zhao, Wei
Zhang, Jinping
Song, Yun
Sun, Lili
Zheng, Meimei
Yin, Hao
Zhang, Jun
Wang, Wei
Han, Ju
Irreversible fatal contrast-induced encephalopathy: a case report
title Irreversible fatal contrast-induced encephalopathy: a case report
title_full Irreversible fatal contrast-induced encephalopathy: a case report
title_fullStr Irreversible fatal contrast-induced encephalopathy: a case report
title_full_unstemmed Irreversible fatal contrast-induced encephalopathy: a case report
title_short Irreversible fatal contrast-induced encephalopathy: a case report
title_sort irreversible fatal contrast-induced encephalopathy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437917/
https://www.ncbi.nlm.nih.gov/pubmed/30922249
http://dx.doi.org/10.1186/s12883-019-1279-5
work_keys_str_mv AT zhaowei irreversiblefatalcontrastinducedencephalopathyacasereport
AT zhangjinping irreversiblefatalcontrastinducedencephalopathyacasereport
AT songyun irreversiblefatalcontrastinducedencephalopathyacasereport
AT sunlili irreversiblefatalcontrastinducedencephalopathyacasereport
AT zhengmeimei irreversiblefatalcontrastinducedencephalopathyacasereport
AT yinhao irreversiblefatalcontrastinducedencephalopathyacasereport
AT zhangjun irreversiblefatalcontrastinducedencephalopathyacasereport
AT wangwei irreversiblefatalcontrastinducedencephalopathyacasereport
AT hanju irreversiblefatalcontrastinducedencephalopathyacasereport